Adnan Aydıner

5PUBLICATIONS
58CO-AUTHORS
Predictive and prognostic markersObstetrics and gynaecologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 29, 2025
Factors Predicting Additional Residual Nodal Disease With a Metastatic Sentinel Node Biopsy or Targeted Axillary Dissection After Neoadjuvant Chemotherapy.

Neslihan Cabıoğlu, Hasan Karanlık, Abdullah Iğci

|May 31, 2023
Termination of trastuzumab in HER2-positive metastatic breast cancer patients who received trastuzumab beyond progression.

Izzet Dogan, Esra Aydin, Nijat Khanmammadov

|Apr 07, 2023
Prognostic Factors Influencing Progression-Free Survival in HER2-Positive Metastatic Breast Cancer Patients Who Were Treated With A Combination of Lapatinib and Capecitabine.

İzzet Doğan, Nail Paksoy, Naziye Ak

|May 25, 2021
Demonstration of in vivo estrogen receptor status with 16α- [<sup>18</sup>F]fluoro-17ß-oestradiol (FES) PET/CT in a rare case of benign metastasizing leiomyoma.

Duygu Has Simsek, Serkan Kuyumcu, Zeynep Gozde Ozkan

|Jan 24, 2020
Efficacy of Palbociclib and Endocrine Treatment in Heavily Pretreated Hormone Receptor-positive/HER2-negative Advanced Breast Cancer: Retrospective Multicenter Trial

Atakan Demir, Nil Molinas Mandel, Semra Paydas

Pageof 1

Frequent Collaborators

3 joint publications

Naziye Ak

2 joint publications

Izzet Dogan

2 joint publications

Pınar Saip

2 joint publications

Sezai Vatansever